ArticleThe American journal of case reports2026
Bloodstream Infection in an Immunocompromised Host After Unusual Presentation of Photo Recall Dermatitis.
Article in The American journal of case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND Photo recall dermatitis (PRD) is a phototoxic eruption that occurs in areas of previous ultraviolet-damaged skin following systemic administration of a drug, most commonly chemotherapeutic medications. Although generally considered a self-limited dermatologic phenomenon, its implications in immunocompromised patients have not been well characterized. Secondary infection complicating PRD has not been previously established in the literature. This case is unique because the patient had an unusual rash while neutropenic, then developed a bloodstream infection (BSI), with the skin as her most likely source. CASE REPORT We describe a case of a woman in her 80s with metastatic pancreatic adenocarcinoma enrolled in a clinical trial of a DNA methyltransferase-inhibiting nucleoside analog who presented with fever, neutropenia, and an erythematous rash localized precisely to areas of a recent sunburn. Dermatologic evaluation supported a diagnosis of photo recall dermatitis. Peripheral blood cultures grew Staphylococcus hominis in 1 of 4 bottles, while concurrent port cultures were negative. She developed clinical signs of a true BSI rather than culture contamination, with the presentation consistent with a skin source as the most likely route of entry rather than a central-line-associated BSI (CLABSI) usually observed with S. hominis infections. CONCLUSIONS This case is, to the best of our knowledge, the first reported instance of photo recall dermatitis complicated by bloodstream infection. It highlights the potential for inflammatory skin barrier disruption to serve as a portal of entry in neutropenic patients. Clinicians should be aware that photo recall dermatitis can lead to infections, including BSIs, in immunocompromised hosts.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.